Division of Biology and Medicine
Legorreta Cancer Center

Cancer Therapeutics Program

Advancing therapeutic options for cancer patients through active clinical trials

Program Leaders

The Cancer Therapeutics Program brings clinical investigators together with basic and translational scientists to advance promising therapeutic options for patients through clinical trials. Program meetings are held every two weeks throughout the year. There is a robust portfolio of early phase clinical trials led by investigators through the Brown University Oncology Group (BrUOG), Brown University Health Cancer Institute and Women's and Infants Hospital. Members of our Cancer Therapeutics program hold a depth of expertise in disease-based adult and pediatric oncology, pathology, and clinical investigations. Early phase experimental therapeutic efforts have a strong focus on cell death pathways and immunotherapy.

Program members interact with the Cancer Biology Program to bring forward novel biomarkers as well as therapeutics into early phase clinical trials. Efforts to translate novel concepts are supported by the Translational Research Disease Groups (TRDGs). TRDG meetings occur in parallel to the Cancer Therapeutics Program Meetings. Each of the 11 disease-based TRDGs meets every 2-3 months, with emerging projects being presented at the Cancer Therapeutics Program meetings.

Members